Florida AIDS Drug Assistance Program Cuts Will Increase HIV Transmission – And Will Be Costly
The federal Ryan White HIV/AIDS Program (RWHAP) and its subprogram, the AIDS Drug Assistance Program (ADAP), have been essential in providing access to medications and HIV-related care for people living with HIV (PWH) in the US. Rates of viral suppression among ADAP recipients are substantially higher than among all PWH, reflecting the program’s effectiveness in connecting vulnerable individuals to high-quality treatment. Florida, the state with the third highest rate of new HIV diagnoses, announced cuts to ADAP that removed first-line antiretroviral therapy from its formulary, restricted income-eligibility requirements, and ended health insurance payment-assistance programs. As researchers studying HIV in Florida, we modeled the potential impact of these funding changes projecting more than 1000 new infections over five years in Miami-Dade County alone and over $1 billion in additional lifetime healthcare costs. Funding cuts to ADAP in Florida and other states will lead to increased HIV transmission and healthcare costs.
Authors
- Natasha K. Martin (ORCID: https://orcid.org/0000-0001-8344-1810)
- Susan J. Little (ORCID: https://orcid.org/0000-0002-7645-9737)
- Lily Ostrer
- Bruce R. Schackman (ORCID: https://orcid.org/0000-0002-1132-2932)
- Ravi Goyal (ORCID: https://orcid.org/0000-0002-0358-2435)
Institutions
- Cornell University (US)
- University of California San Diego (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1093/ofid/ofag755
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00